TIMOTHY SHORT: Open Payments
NPI 1114696069 · ADRIAN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$686 in 38 payments from 11 companies in 2025. Trend: 2023 $400 · 2024 $477 · 2025 $686
Food & beverage: $686
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $178 |
| AstraZeneca Pharmaceuticals LP | 6 | $120 |
| Lilly USA, LLC | 5 | $103 |
| Novo Nordisk Inc | 4 | $78 |
| GlaxoSmithKline, LLC. | 3 | $51 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Exact Sciences Corporation | 2 | $37 |
| Bioventus LLC | 1 | $22 |
| PFIZER INC. | 1 | $22 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
Products named: VRAYLAR, AIRSUPRA, MOUNJARO, SHINGRIX, REXULTI, Wegovy, Cologuard Collection Kit, XCELL.
Industry payments across MI — which companies pay providers there.
